Disc Medicine Inc (IRON)
33.91
-0.72
(-2.08%)
USD |
NASDAQ |
May 31, 16:00
33.94
+0.03
(+0.09%)
After-Hours: 20:00
Disc Medicine 1 Year Total Returns (Daily): -8.67% for May 31, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 31, 2024 | -8.67% |
May 30, 2024 | 4.46% |
May 29, 2024 | 4.95% |
May 28, 2024 | 6.55% |
May 24, 2024 | 5.80% |
May 23, 2024 | 0.45% |
May 22, 2024 | -1.07% |
May 21, 2024 | -7.51% |
May 20, 2024 | -4.23% |
May 17, 2024 | -5.49% |
May 16, 2024 | -4.40% |
May 15, 2024 | -0.44% |
May 14, 2024 | -4.10% |
May 13, 2024 | -6.60% |
May 10, 2024 | -9.99% |
May 09, 2024 | -3.99% |
May 08, 2024 | -5.51% |
May 07, 2024 | -1.93% |
May 06, 2024 | -1.50% |
May 03, 2024 | -5.58% |
May 02, 2024 | -11.04% |
May 01, 2024 | -17.57% |
April 30, 2024 | -14.94% |
April 29, 2024 | -13.57% |
April 26, 2024 | -13.06% |
Date | Value |
---|---|
April 25, 2024 | -11.75% |
April 24, 2024 | -8.54% |
April 23, 2024 | -13.88% |
April 22, 2024 | -13.94% |
April 19, 2024 | 11.37% |
April 18, 2024 | 18.19% |
April 17, 2024 | 30.57% |
April 16, 2024 | 36.36% |
April 15, 2024 | 39.04% |
April 12, 2024 | 48.05% |
April 11, 2024 | 47.24% |
April 10, 2024 | 48.12% |
April 09, 2024 | 42.51% |
April 08, 2024 | 41.18% |
April 05, 2024 | 35.46% |
April 04, 2024 | 39.22% |
April 03, 2024 | 39.14% |
April 02, 2024 | 51.18% |
April 01, 2024 | 61.44% |
March 28, 2024 | 182.6% |
March 27, 2024 | 167.9% |
March 26, 2024 | 164.7% |
March 25, 2024 | 161.2% |
March 22, 2024 | 180.2% |
March 21, 2024 | 176.1% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.06%
Minimum
Mar 15 2022
329.1%
Maximum
Dec 27 2023
59.16%
Average
40.20%
Median
Feb 10 2023
1 Year Total Returns (Daily) Benchmarks
ACADIA Pharmaceuticals Inc | -35.83% |
Alnylam Pharmaceuticals Inc | -19.77% |
Marinus Pharmaceuticals Inc | -80.07% |
Rocket Pharmaceuticals Inc | 1.77% |
Regenxbio Inc | -16.72% |